Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
Anti-Human Integrin α 4 β 7 MAb, Human IgG1 (ADCC Disable) captured on Protein A Chip can bind Human ITGA4&ITGB7 Heterodimer Protein, His Tag&Tag Free (IT7-H52W4) with an affinity constant of 1.37 nM as determined in a SPR assay (Biacore 8K) (QC tested).
The purity of Human ITGA4&ITGB7 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT7-H52W4) is more than 85% and the molecular weight of this protein is around 210-250 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Carotegrast methyl | AJM-300 | Approved | Ea Pharma, Eisai Co Ltd | Carogra | Japan | Colitis, Ulcerative | Ea Pharma Co Ltd | 2022-03-28 | Colitis, Ulcerative | Details |
| Vedolizumab | MLN-0002; LPD-02; MLN-002; MLN-02; LDP-02 | Approved | Millennium Pharmaceuticals Inc | 安吉优, Entyvio | EU | Pouchitis | Takeda Pharma A/S | 2014-05-20 | HIV Infections; Acquired Immunodeficiency Syndrome; Solid tumours; Inflammatory Bowel Diseases; Pediatric Crohn's disease; Pouchitis; Colitis; Celiac Disease; Cholangitis, Sclerosing; Pediatric ulcerative colitis; Colitis, Ulcerative; Urogenital Neoplasms; Crohn Disease; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
| Natalizumab | BG-0002; TY-21.6; AN-10022; BG-00002; AN-100226; BG-0002-E | Approved | Biogen Inc, Perrigo Llc | Tysabri, Antegran, Antegren | Japan | Multiple Sclerosis | Biogen Inc | 2004-11-23 | Multiple Sclerosis, Relapsing-Remitting; Epilepsies, Partial; Arthritis, Rheumatoid; Graft vs Host Disease; Stroke; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Multiple Myeloma; Demyelinating Diseases; Myositis, Inclusion Body; Crohn Disease | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| TRK-170 | TRK-170 | Toray Industries Inc | Details | ||
| ABBV-382 | Phase 1 Clinical | Abbvie Inc | HIV Infections | Details | |
| PTG-100 | PTG-100 | Phase 1 Clinical | Protagonist Therapeutics Inc | Celiac Disease; Colitis, Ulcerative | Details |
| PN-10943 | PN-10943-A; PN-10943; PN-943 | Phase 2 Clinical | Protagonist Therapeutics Inc | Colitis, Ulcerative | Details |
| Etrolizumab | PRO-145223; rhuMAb-Beta7; R-7413; RG-7413 | Phase 3 Clinical | Genentech Inc | Colitis, Ulcerative; Crohn Disease | Details |
| Natalizumab biosimilar (Polpharma Biologics) | PB-006 | Phase 3 Clinical | Polpharma Biologics Sa | Multiple Sclerosis, Relapsing-Remitting | Details |
| MORF-057 | MORF-057 | Phase 2 Clinical | Morphic Therapeutic Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative | Details |
| GS-1427 | GS-1427 | Phase 1 Clinical | Gilead Sciences Sl | Inflammatory Bowel Diseases | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
